Global Antimicrobial Susceptibility Market Size study, by Type (Tests & Kits, Culture Media, Automated Test System, Consumables), by Method (Broth Dilution Method, Rapid Automated Method, Disk Diffusion Method, Gradient Diffusion Method, Molecular Testing Method), by Type (Antibacterial, Anitfungal, Antiparasitics, Others) by End User (Diagnostic Laboratories and Hospitals, Pharmaceutical and Biotechnology Companies, Research And Academic Institutes, Contract research organizations)and Regional Forecasts 2018-2025
![](/report_cover/10760/global-antimicrobial-susceptibility-market-size-study-type-method-type-by-end-user-regional-forecasts-2018-2025_en.gif)
Global Antimicrobial Susceptibility Market to reach USD 4.1 billion by 2025.
Global Antimicrobial Susceptibility Market is valued approximately USD 2.7 million in 2017 and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2018-2025. Antimicrobial Susceptibility is developing and expanding at a significant pace. Antimicrobial susceptibility tests are utilized to determine the specific antibiotics which are used in order to treat a specific type of infection that is caused by fungus or bacteria. Antimicrobial susceptibility testing is pivotal to identify the patients or individuals’ antibiotic treatment & fight against the antibiotic resistance present in the environment. The Antimicrobial susceptibility is mainly driven owing to rise in number of bacterial & fungal infections in both the male and female population on the globe beginning from 2017 to 2025. The factors which includes rise in microbial resistance, need of new broad spectrum antibiotics, surge in number of bacterial infections and increase in awareness about the infection control in healthcare system is fueling the adoption and utility of antimicrobial susceptibility test market on the global scenario. However, inefficient diagnosis, patent expirations, low patient compliance and lack of return on investment along with stringent regulatory norms and policies are the factors which are acting as restraining factors considering the growth of antimicrobial susceptibility market.
The regional analysis of Global Antimicrobial Susceptibility Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the fastest growing region across the world in terms of market share. Whereas, owing to the countries such as China, Japan, and India, Asia Pacific region is anticipated to be the dominating region over the forecast period 2018-2025.
The leading market players include-
By Test:
Global Antimicrobial Susceptibility Market is valued approximately USD 2.7 million in 2017 and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2018-2025. Antimicrobial Susceptibility is developing and expanding at a significant pace. Antimicrobial susceptibility tests are utilized to determine the specific antibiotics which are used in order to treat a specific type of infection that is caused by fungus or bacteria. Antimicrobial susceptibility testing is pivotal to identify the patients or individuals’ antibiotic treatment & fight against the antibiotic resistance present in the environment. The Antimicrobial susceptibility is mainly driven owing to rise in number of bacterial & fungal infections in both the male and female population on the globe beginning from 2017 to 2025. The factors which includes rise in microbial resistance, need of new broad spectrum antibiotics, surge in number of bacterial infections and increase in awareness about the infection control in healthcare system is fueling the adoption and utility of antimicrobial susceptibility test market on the global scenario. However, inefficient diagnosis, patent expirations, low patient compliance and lack of return on investment along with stringent regulatory norms and policies are the factors which are acting as restraining factors considering the growth of antimicrobial susceptibility market.
The regional analysis of Global Antimicrobial Susceptibility Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the fastest growing region across the world in terms of market share. Whereas, owing to the countries such as China, Japan, and India, Asia Pacific region is anticipated to be the dominating region over the forecast period 2018-2025.
The leading market players include-
- Thermo Fisher Scientific Inc
- Becton and Dickinson Company
- Creative DIagnostics
- HiMedia Laboratories
- Alifax Holding S.P.A
- Danaher Corporation
- Biotron Healthcare
- Beckman Coulter, Inc
By Test:
- Test & Kits
- Culture Media
- Automated Test System
- Consumables
- Broth Dilution Method
- Rapid Automated Method
- Disk Diffusion Method
- Gradient Diffusion Method
- Molecular Testing Method
- Antibacterial
- Antifungal
- Antiparasitics
- Others
- Diagnostic Laboratories and Hospitals
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutes
- Contract Research Organizations
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- China
- India
- Japan
- Latin America
- Brazil
- Mexico
- Rest of the World
- Historical year – 2015, 2016
- Base year – 2017
- Forecast period – 2018 to 2025
- Key Consulting Companies & Advisors
- Large, medium-sized, and small enterprises
- Venture capitalists
- Value-Added Resellers (VARs)
- Third-party knowledge providers
- Investment bankers
- Investors
CHAPTER 1. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET DEFINITION AND SCOPE
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
CHAPTER 3. EXECUTIVE SUMMARY
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends
CHAPTER 4. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET DYNAMICS
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, BY PRODUCT TYPE
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, Sub Segment Analysis
5.3.1. Test & Kits
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2. Culture Media
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.3. Automated Test System
5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.4. Consumables
5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 6. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, BY METHOD
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, Sub Segment Analysis
6.3.1. Broth Dilution Method
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.2. Rapid Automated Method
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.3. Disk Diffusion Method
6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.4. Gradient Diffusion Method
6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.5. Molecular Testing Method
6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 7. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, BY TEST TYPE
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, Sub Segment Analysis
7.3.1. Antibacterial
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Antifungal
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. Anti-parasites
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4. Others
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 8. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, BY END USERS
8.1. Market Snapshot
8.2. Market Performance - Potential Model
8.3. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, Sub Segment Analysis
8.3.1. Diagnostic Laboratories and Hospitals
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Pharmaceutical and Biotechnology Companies
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. Research and Academic Institutes
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4. Contract Research Organizations
8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 9. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, BY REGIONAL ANALYSIS
9.1. ANTIMICROBIAL SUSCEPTIBILITY MARKET, Regional Market Snapshot (2015-2025)
9.2. North America ANTIMICROBIAL SUSCEPTIBILITY MARKET Snapshot
9.2.1. U.S.
9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2. Canada
9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3. Europe ANTIMICROBIAL SUSCEPTIBILITY MARKET Snapshot
9.3.1. U.K.
9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2. Germany
9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3. France
9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4. Rest of Europe
9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia ANTIMICROBIAL SUSCEPTIBILITY MARKET Snapshot
9.4.1. China
9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2. India
9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3. Japan
9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4. Rest of Asia Pacific
9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Latin America ANTIMICROBIAL SUSCEPTIBILITY MARKET Snapshot
9.5.1. Brazil
9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2. Mexico
9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6. Rest of The World
9.6.1. South America
9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2. Middle East and Africa
9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Bio-Rad Laboratories
10.3.1.1. Overview
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Product Summary
10.3.1.4. Recent Developments
10.3.2. Backman Coulter, Inc
10.3.3. Thermo Fisher Scientific, Inc
10.3.4. Becton, Dickinson and Company
10.3.5. HiMedia Laboratories
10.3.6. Danaher Corporation
10.3.7. Creative Diagnostics
10.3.8. Alifax Holding S.P.A
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
CHAPTER 3. EXECUTIVE SUMMARY
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends
CHAPTER 4. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET DYNAMICS
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, BY PRODUCT TYPE
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, Sub Segment Analysis
5.3.1. Test & Kits
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2. Culture Media
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.3. Automated Test System
5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.4. Consumables
5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 6. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, BY METHOD
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, Sub Segment Analysis
6.3.1. Broth Dilution Method
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.2. Rapid Automated Method
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.3. Disk Diffusion Method
6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.4. Gradient Diffusion Method
6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.5. Molecular Testing Method
6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 7. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, BY TEST TYPE
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, Sub Segment Analysis
7.3.1. Antibacterial
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Antifungal
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. Anti-parasites
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4. Others
7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 8. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, BY END USERS
8.1. Market Snapshot
8.2. Market Performance - Potential Model
8.3. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, Sub Segment Analysis
8.3.1. Diagnostic Laboratories and Hospitals
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Pharmaceutical and Biotechnology Companies
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. Research and Academic Institutes
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4. Contract Research Organizations
8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 9. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY MARKET, BY REGIONAL ANALYSIS
9.1. ANTIMICROBIAL SUSCEPTIBILITY MARKET, Regional Market Snapshot (2015-2025)
9.2. North America ANTIMICROBIAL SUSCEPTIBILITY MARKET Snapshot
9.2.1. U.S.
9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2. Canada
9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.2.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3. Europe ANTIMICROBIAL SUSCEPTIBILITY MARKET Snapshot
9.3.1. U.K.
9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2. Germany
9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3. France
9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.3.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4. Rest of Europe
9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.3.4.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4. Asia ANTIMICROBIAL SUSCEPTIBILITY MARKET Snapshot
9.4.1. China
9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2. India
9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3. Japan
9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.3.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4. Rest of Asia Pacific
9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.4.4.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5. Latin America ANTIMICROBIAL SUSCEPTIBILITY MARKET Snapshot
9.5.1. Brazil
9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2. Mexico
9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.5.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6. Rest of The World
9.6.1. South America
9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.1.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2. Middle East and Africa
9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.2. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.3. Method breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.4. Test Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
9.6.2.5. End User breakdown estimates & forecasts, 2015-2025 (USD Billion)
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Company Market Share (Subject to Data Availability)
10.2. Top Market Strategies
10.3. Bio-Rad Laboratories
10.3.1.1. Overview
10.3.1.2. Financial (Subject to Data Availability)
10.3.1.3. Product Summary
10.3.1.4. Recent Developments
10.3.2. Backman Coulter, Inc
10.3.3. Thermo Fisher Scientific, Inc
10.3.4. Becton, Dickinson and Company
10.3.5. HiMedia Laboratories
10.3.6. Danaher Corporation
10.3.7. Creative Diagnostics
10.3.8. Alifax Holding S.P.A